Surgical Approaches for Repigmenting Vitiligo 2.0

Significant advances in understanding vitiligo have led to new treatments, such as ruxolitinib cream, though it often fails to achieve complete repigmentation, especially on hands and feet. Surgical approaches, like melanocyte grafts, are proposed for stable vitiligo but have low success rates. A study found that the absence of initial CD8+ T cell infiltrates in vitiligo lesions predicts better surgical outcomes. This suggests that assessing CD8+ T cell levels before surgery could identify good candidates for grafting. Combining surgery with immunomodulating agents may improve outcomes for lesions with CD8+ T cell infiltrates. Prospective trials are needed to confirm these findings and optimize treatment strategies.